Experience of patients and healthcare practitioners with interdisciplinary care in immune‐mediated inflammatory diseases with skin manifestations: A systematic scoping review
The heterogeneous way in how IC experience is captured hinders strong conclusions, which mandates the development of standardized analysis tools. Experience with IC in skIMIDs strongly depends on the context of the provided IC and patient experience seems to be better in local IC programmes than systems rolled out in larger geographical regions. Future need is to develop a core IC outcome set including medical outcomes, process indicators, financial indicators, plus patient and HCP care experience measures.
Authors
- Diederik De Cock (ORCID: https://orcid.org/0000-0002-5656-6236)
- Jan Gutermuth (ORCID: https://orcid.org/0000-0002-9252-6004)
- Jo Lambert (ORCID: https://orcid.org/0000-0001-5303-9310)
- Ellen Van den Steen (ORCID: https://orcid.org/0000-0002-2430-9673)
- Valérie Reynaert (ORCID: https://orcid.org/0000-0001-7992-0579)
- Branka Marinović (ORCID: https://orcid.org/0000-0001-8441-5016)
- Kilian Eyerich (ORCID: https://orcid.org/0000-0003-0094-2674)
Institutions
- Vrije Universiteit Brussel (BE)
- University Hospital Centre Zagreb (HR)
- University of Freiburg (DE)
- University of Zagreb (HR)
- Ghent University Hospital (BE)
- Ghent University (BE)
- Universitair Ziekenhuis Brussel (BE)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2024-12-07
- DOI
- https://doi.org/10.1111/jdv.20449
- Citations
- 2
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- European Academy of Dermatology and Venereology
- Janssen Pharmaceuticals